![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Römkens Tessa E.H. Kampschreur Milou T. Drenth Joost P.H. van Oijen Martijn G.H. de Jong Dirk J.
Publisher: Blackwell Publishing
ISSN: 1078-0998
Source: Inflammatory Bowel Diseases, Vol.18, Iss.11, 2012-11, pp. : 2190-2198
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 1, 2010-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mucosal Healing in Ulcerative Colitis: Where do we Stand?
Current Drug Targets, Vol. 12, Iss. 10, 2011-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
American Journal of Cardiovascular Drugs, Vol. 11, Iss. 2, 2011-04 ,pp. :